Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1971 1
1973 2
1976 2
1977 1
1980 1
1995 1
1996 1
1997 1
1998 1
1999 1
2004 1
2005 2
2006 1
2007 3
2011 1
2019 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
The Spectrum of SPTA1-Associated Hereditary Spherocytosis.
Chonat S, Risinger M, Sakthivel H, Niss O, Rothman JA, Hsieh L, Chou ST, Kwiatkowski JL, Khandros E, Gorman MF, Wells DT, Maghathe T, Dagaonkar N, Seu KG, Zhang K, Zhang W, Kalfa TA. Chonat S, et al. Among authors: wells dt. Front Physiol. 2019 Jul 3;10:815. doi: 10.3389/fphys.2019.00815. eCollection 2019. Front Physiol. 2019. PMID: 31333484 Free PMC article.
Corrigendum: The Spectrum of SPTA1-Associated Hereditary Spherocytosis.
Chonat S, Risinger M, Sakthivel H, Niss O, Rothman JA, Hsieh L, Chou ST, Kwiatkowski JL, Khandros E, Gorman MF, Wells DT, Maghathe T, Dagaonkar N, Seu KG, Zhang K, Zhang W, Kalfa TA. Chonat S, et al. Among authors: wells dt. Front Physiol. 2019 Oct 18;10:1331. doi: 10.3389/fphys.2019.01331. eCollection 2019. Front Physiol. 2019. PMID: 31736770 Free PMC article.
Safety and tolerability of olopatadine 0.2% in children and adolescents.
Lichtenstein SJ, Pasquine TA, Edwards MR, Wells DT, Gross RD, Robertson SM. Lichtenstein SJ, et al. Among authors: wells dt. J Ocul Pharmacol Ther. 2007 Aug;23(4):366-71. doi: 10.1089/jop.2007.0013. J Ocul Pharmacol Ther. 2007. PMID: 17803435 Clinical Trial.
Large magnitude voluntary heart rate changes.
Wells DT. Wells DT. Psychophysiology. 1973 May;10(3):260-9. doi: 10.1111/j.1469-8986.1973.tb00525.x. Psychophysiology. 1973. PMID: 4702520 No abstract available.
The safety and intraocular pressure-lowering efficacy of brimonidine tartrate 0.15% preserved with polyquaternium-1.
Whitson JT, Ochsner KI, Moster MR, Sullivan EK, Andrew RM, Silver LH, Wells DT, James JE, Bosworth CF, Dickerson JE, Landry TA, Bergamini MV; Brimonidine 0.15% Study Group. Whitson JT, et al. Among authors: wells dt. Ophthalmology. 2006 Aug;113(8):1333-9. doi: 10.1016/j.ophtha.2006.03.025. Ophthalmology. 2006. PMID: 16877072 Clinical Trial.
Clinical efficacy of olopatadine hydrochloride ophthalmic solution 0.2% compared with placebo in patients with allergic conjunctivitis or rhinoconjunctivitis: a randomized, double-masked environmental study.
Abelson MB, Gomes PJ, Vogelson CT, Pasquine TA, Gross RD, Turner FD, Wells DT, Bergamini MV, Robertson SM. Abelson MB, et al. Among authors: wells dt. Clin Ther. 2004 Aug;26(8):1237-48. doi: 10.1016/s0149-2918(04)80065-1. Clin Ther. 2004. PMID: 15476905 Clinical Trial.
23 results